Day Zero Diagnostics, an infectious disease diagnostics company co-founded by Miriam Huntley, Ph.D. ’16 (applied math) has received a Phase I Small Business Innovation Research award from the National Institute of Allergies and Infectious Disease (NIAID) of the National Institutes of Health (NIH).
The award will support the integration of ultra-long read genomic sequencing from Oxford Nanopore Technologies into the company’s epiXact® service for rapidly detecting healthcare-associated infection outbreaks.